VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $22.34 million. The enterprise value is -$2.59 million.
| Market Cap | 22.34M |
| Enterprise Value | -2.59M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VYNE has 33.35 million shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | 33.35M |
| Shares Outstanding | 33.35M |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 36.97% |
| Float | 30.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 49.21 |
| Forward PS | 37.23 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.86
| Current Ratio | 20.86 |
| Quick Ratio | 20.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.16% and return on invested capital (ROIC) is -44.25%.
| Return on Equity (ROE) | -63.16% |
| Return on Assets (ROA) | -37.01% |
| Return on Invested Capital (ROIC) | -44.25% |
| Return on Capital Employed (ROCE) | -98.91% |
| Weighted Average Cost of Capital (WACC) | 15.28% |
| Revenue Per Employee | $45,400 |
| Profits Per Employee | -$2.15M |
| Employee Count | 10 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VYNE has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.00% in the last 52 weeks. The beta is 2.01, so VYNE's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | -53.00% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 56.08 |
| Average Volume (20 Days) | 164,643 |
Short Selling Information
The latest short interest is 110,099, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 110,099 |
| Short Previous Month | 120,420 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 0.75 |
Income Statement
In the last 12 months, VYNE had revenue of $454,000 and -$21.46 million in losses. Loss per share was -$0.50.
| Revenue | 454,000 |
| Gross Profit | 454,000 |
| Operating Income | -24.37M |
| Pretax Income | -21.71M |
| Net Income | -21.46M |
| EBITDA | -24.35M |
| EBIT | -24.37M |
| Loss Per Share | -$0.50 |
Balance Sheet
The company has $24.93 million in cash and n/a in debt, with a net cash position of $24.93 million or $0.75 per share.
| Cash & Cash Equivalents | 24.93M |
| Total Debt | n/a |
| Net Cash | 24.93M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 24.64M |
| Book Value Per Share | 0.74 |
| Working Capital | 24.55M |
Cash Flow
| Operating Cash Flow | -25.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 23,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.74M |
| FCF Per Share | -$0.77 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -5,367.40% |
| Pretax Margin | -4,782.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.42% |
| Shareholder Yield | -0.42% |
| Earnings Yield | -96.05% |
| FCF Yield | -115.24% |
Analyst Forecast
The average price target for VYNE is $2.00, which is 198.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.00 |
| Price Target Difference | 198.60% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
VYNE has an Altman Z-Score of -35.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.33 |
| Piotroski F-Score | 2 |